In Vivo Cellular Infiltration and Remodeling in a Decellularized Ovine Osteochondral Allograft.
Interest in decellularized tissues has steadily gained as potential solutions for degenerative diseases and traumatic events, replacing sites of missing tissue, and providing the relevant biochemistry and microstructure for tissue ingrowth and regeneration. Osteoarthritis, a progressive and debilitating disease, is often initiated with the formation of a focal defect in the otherwise smooth surface of articular cartilage. Decellularized cartilage tissue, which maintains the structural complexity of the native extracellular matrix, has the potential to provide a clinically relevant solution to focal defects or large tissue damage, possibly even circumventing or complementing current techniques such as microfracture and mosaicplasty. However, it is currently unclear whether implantation of decellularized cartilage in vivo may provide a mechanically and biochemically relevant platform to promote cell remodeling and repair. We examined whole decellularized osteochondral allografts implanted in the ovine trochlear groove to investigate cellular remodeling and repair tissue quality compared to empty defects and contralateral controls (healthy cartilage). At 3 months postsurgery, cells were observed in both the decellularized tissue and empty defects, although both at significantly lower levels than healthy cartilage. Qualitative and quantitative histological analysis demonstrated maintenance of cartilage features of the decellularized implant similar to healthy cartilage groups. Noninvasive analysis by quantitative magnetic resonance imaging showed no difference in T1ρand T2* between all groups. Investigation of the mechanical properties of repair tissue showed significantly lower elasticity in decellularized implants and empty defects compared to healthy cartilage, but similar tribological quantities. Overall, this study suggests that decellularized cartilage implants are subject to cellular remodeling in an in vivo environment and may provide a potential tissue engineering solution to cartilage defect interventions.
1 Weldon School of Biomedical Engineering, Purdue University , West Lafayette, Indiana.
Tyler
T
Novak
1 Weldon School of Biomedical Engineering, Purdue University , West Lafayette, Indiana.
Kateri
K
Fites Gilliland
1 Weldon School of Biomedical Engineering, Purdue University , West Lafayette, Indiana.|2 Department of Mechanical Engineering, University of Colorado Boulder , Boulder, Colorado.
Xin
X
Xu
1 Weldon School of Biomedical Engineering, Purdue University , West Lafayette, Indiana.
Logan
L
Worke
3 Purdue University-North Central , Westville, Indiana.
Aaron
A
Ciesielski
4 Department of Veterinary Clinical Sciences, Purdue University , West Lafayette, Indiana.
Gert
G
Breur
1 Weldon School of Biomedical Engineering, Purdue University , West Lafayette, Indiana.|2 Department of Mechanical Engineering, University of Colorado Boulder , Boulder, Colorado.
Corey P
CP
Neu
D064591:Allografts; D000818:Animals; D002356:Cartilage / Q000737:chemistry*; D005109:Extracellular Matrix / Q000737:chemistry*; D020007:Implants, Experimental; D012756:Sheep; D014457:Ulna / Q000378:metabolism*
cartilage tissue engineering; cell remodeling and regeneration; decellularization; defect repair; recellularization
J Colloid Interface Sci. 2000 Jul 1;227(1):55-65
10860594
Tissue Eng. 2000 Oct;6(5):567-76
11074942
Magn Reson Med. 2004 Nov;52(5):1103-9
15508163
Stem Cells. 2005 Feb;23(2):288-96
15671151
Osteoarthritis Cartilage. 2007 May;15(5):566-74
17157538
Rev Sci Instrum. 2007 Jan;78(1):013705
17503926
Arthritis Rheum. 2007 Nov;56(11):3706-14
17968924
Biomaterials. 2008 May;29(15):2378-87
18313139
Tissue Eng Part A. 2009 Feb;15(2):231-41
18950290
Biomaterials. 2009 Aug;30(22):3749-56
19395023
Osteoarthritis Cartilage. 2009 Nov;17(11):1461-8
19447213
Tissue Eng Part A. 2010 Feb;16(2):523-33
19715387
Am J Manag Care. 2009 Sep;15(8 Suppl):S230-5
19817509
Am J Sports Med. 2010 May;38(5):880-90
20203290
Osteoarthritis Cartilage. 2010 Jul;18(7):956-63
20417298
Arthritis Rheum. 2010 Sep;62(9):2680-7
20499384
Biomaterials. 2011 Mar;32(9):2265-73
21194746
J Biomech. 2011 Apr 29;44(7):1340-5
21316681
J Biomech. 2011 Oct 13;44(15):2667-72
21920526
J Magn Reson Imaging. 2012 Apr;35(4):891-8
22128105
J Orthop Res. 2012 Mar;30(3):393-400
22267189
J Tissue Eng Regen Med. 2014 Jun;8(6):442-53
22674864
Tissue Eng Part A. 2012 Nov;18(21-22):2195-209
22690787
J R Soc Interface. 2013 Jan 6;10(78):20120608
23135247
Science. 2012 Nov 16;338(6109):917-21
23161992
Trends Biotechnol. 2013 Mar;31(3):169-76
23298610
J Cell Biol. 2013 Jun 24;201(7):1069-84
23798731
J Biomed Mater Res A. 2014 Jul;102(7):2248-57
23913750
PLoS One. 2013 Oct 18;8(10):e76658
24204653
Biotechnol Adv. 2014 Mar-Apr;32(2):462-84
24417915
J Cell Biol. 2014 Mar 3;204(5):669-82
24567359
Skeletal Radiol. 2014 Oct;43(10):1429-45
24643762
PLoS One. 2014 May 15;9(5):e97486
24830386
Acta Biomater. 2015 Jan;11:274-82
25257315
Biomed Mater. 2015 Jan 13;10(1):015010
25586138
Tissue Eng Part C Methods. 2015 Sep;21(9):971-86
25919905
Adv Funct Mater. 2016 Apr 25;26(16):2617-2628
27346992
Adv Funct Mater. 2016 Aug 9;26(30):5427-5436
28824356
J Clin Invest. 1994 Apr;93(4):1722-32
7512992
Methods Enzymol. 1995;248:47-58
7674938
J Orthop Res. 1998 Jan;16(1):89-95
9565078
J Orthop Res. 1998 Jul;16(4):490-9
9747792